[{"id":"5992e1f2-63b6-45f1-8c22-41240b0aaf81","acronym":"","url":"https://clinicaltrials.gov/study/NCT03995472","created_at":"2022-07-14T16:59:43.900Z","updated_at":"2024-07-02T16:35:35.528Z","phase":"Phase 1","brief_title":"A Study of SHR-1501 Combined With SHR-1316 in Patients With Advanced Tumors","source_id_and_acronym":"NCT03995472","lead_sponsor":"Jiangsu HengRui Medicine Co., Ltd.","biomarkers":" CD8","pipe":"","alterations":" ","tags":["CD8"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AiRuiLi (adebrelimab) • SHR-1501"],"overall_status":"Completed","enrollment":" Enrollment 14","initiation":"Initiation: 02/14/2020","start_date":" 02/14/2020","primary_txt":" Primary completion: 01/12/2023","primary_completion_date":" 01/12/2023","study_txt":" Completion: 01/12/2023","study_completion_date":" 01/12/2023","last_update_posted":"2023-09-27"}]